|Day Low/High||45.27 / 45.85|
|52 Wk Low/High||40.01 / 63.86|
The generic drugmaker shows new signs of life after months of struggle.
Traders have become more optimistic and forgiving, and that shift in perception can lead us higher.
Mild winter weather has affected many companies' sales and may be distorting the market view.
Traders awaited Greek debt-related news, testimony from Bernanke and some high-profile earnings reports.
U.S. equity futures were higher Friday on the agreement reached in Europe.
These stocks have been making big moves -- up and down -- despite the market whipsaws caused by Europe.
This drop hasn't got far to go, but short sellers will get another, and perhaps better, chance.
The news out of Europe is vague enough to get something going tomorrow, but nothing huge.
Insider selling can indicate that the stock has run too far or business prospects have dimmed.